Literature DB >> 15914774

Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism.

Yung-Chang Chen1, Melissa A Cadnapaphornchai, Jianhui Yang, Sandra N Summer, Sandor Falk, Chunling Li, Weidong Wang, Robert W Schrier.   

Abstract

The purpose of this study was to examine protein expression of renal aquaporins (AQP) and ion transporters in hypothyroid (HT) rats in response to an oral water load compared with controls (CTL) and HT rats replaced with l-thyroxine (HT+T). Hypothyroidism was induced by aminotriazole administration for 10 wk. Body weight, water intake, urine output, solute and urea excretion, and serum and urine osmolality were comparable among the three groups at the conclusion of the 10-wk treatment period. One hour after oral gavage of water (50 ml/kg body wt), HT rats demonstrated significantly less water excretion, higher minimal urinary osmolality, and decreased serum osmolality compared with CTL and HT+T rats. Despite the hyposmolality, plasma vasopressin concentration was elevated in HT rats. These findings in HT rats were associated with an increase in protein abundance of renal cortex AQP1 and inner medulla AQP2. AQP3, AQP4, and the Na-K-2Cl cotransporter were also increased. Moreover, 1 h following the oral water load, HT rats demonstrated a significant increase in the membrane-to-vesicle fraction of AQP2 by Western blot analysis. The defect in urinary dilution in HT rats was reversed by the V(2) vasopressin antagonist OPC-31260. In conclusion, impaired urinary dilution in HT rats is primarily compatible with the nonosmotic release of vasopressin and increased protein expression of renal AQP2. The impairment of maximal solute-free water excretion in HT rats, however, appears also to involve diminished distal fluid delivery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15914774     DOI: 10.1152/ajprenal.00384.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  13 in total

1.  Acute tubular necrosis (ATN) presenting with an unusually prolonged period of marked polyuria heralded by an abrupt oliguric phase.

Authors:  Virin Ramoutar; Cristian Landa; Leighton R James
Journal:  BMJ Case Rep       Date:  2014-08-22

2.  Day-night variations in thyroid stimulating hormone and its relation with clinical status and metabolic parameters in patients with cirrhosis of the liver.

Authors:  Roni Atalay; Reyhan Ersoy; Aylin Bolat Demirezer; Fatma Ebru Akın; Sefika Burcak Polat; Bekir Cakir; Osman Ersoy
Journal:  Endocrine       Date:  2014-07-26       Impact factor: 3.633

Review 3.  Hyponatraemia: more than just a marker of disease severity?

Authors:  Robert W Schrier; Shailendra Sharma; Dmitry Shchekochikhin
Journal:  Nat Rev Nephrol       Date:  2012-11-20       Impact factor: 28.314

4.  Relationship between the seasonal changes in plasma testosterone and thyroxine concentrations with sperm cryoresistance in Gabon bucks.

Authors:  Viera María Noel; Ungerfeld Rodolfo; Velázquez Rosario; Santiago-Moreno Julián
Journal:  Trop Anim Health Prod       Date:  2021-06-25       Impact factor: 1.559

5.  Abnormal function of the vasopressin-cyclic-AMP-aquaporin2 axis during urine concentrating and diluting in patients with reduced renal function. A case control study.

Authors:  Erling B Pedersen; Ingrid M Thomsen; Thomas G Lauridsen
Journal:  BMC Nephrol       Date:  2010-10-05       Impact factor: 2.388

Review 6.  Vasopressin and aquaporin 2 in clinical disorders of water homeostasis.

Authors:  Robert W Schrier
Journal:  Semin Nephrol       Date:  2008-05       Impact factor: 5.299

7.  Effects of Thyroid Hormone on Urinary Concentrating Ability.

Authors:  Elske T Massolt; Mahdi Salih; Carolien M Beukhof; Boen L R Kam; J W Burger; W Edward Visser; Ewout J Hoorn; Robin P Peeters
Journal:  Eur Thyroid J       Date:  2017-07-03

8.  Molecular mechanisms of clinical concentrating and diluting disorders.

Authors:  Robert W Schrier
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

9.  Myxedema coma: a new look into an old crisis.

Authors:  Vivek Mathew; Raiz Ahmad Misgar; Sujoy Ghosh; Pradip Mukhopadhyay; Pradip Roychowdhury; Kaushik Pandit; Satinath Mukhopadhyay; Subhankar Chowdhury
Journal:  J Thyroid Res       Date:  2011-09-15

10.  Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.

Authors:  Jung Eun Lee; Seung Kyu Kim; Kyung Hwa Han; Mi Ok Cho; Gi Young Yun; Ki Hyun Kim; Hoon Young Choi; Young Hoon Ryu; Sung Kyu Ha; Hyeong Cheon Park
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.